Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome

Hormones

Volumn 14, Issue 1, 2015, Pages 101-108

  Savic Radojevic, Ana ^a   Antic, Ivana Bozic ^a   Coric, Vesna ^a   Bjekic Macut, Jelica ^a   Radic, Tanja ^a   Zarkovic, Milos ^a   Djukic, Tatjana ^a   Pljesa Ercegovac, Marija ^a   Panidis, Dimitrios ^b   Katsikis, Ilias ^b   Simic, Tatjana ^a   Macut, Djuro ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Glutathione peroxidase; Insulin resistance; Nitrotyrosine; Oxidative stress; Polycystic ovary syndrome

Indexed keywords

C REACTIVE PROTEIN; GLUTATHIONE PEROXIDASE; GLUCOSE BLOOD LEVEL;

ADULT; AMENORRHEA; ANOVULATION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MONONUCLEAR CELL; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; OXIDATION; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; METABOLISM; OBESITY; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLUTATHIONE PEROXIDASE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; OBESITY; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME;

EID: 84927608977     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S, 2012 The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol 10: 49.
2. Gonzalez F, Rote NS, Minium J, Kirwan JP, 2006 Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91: 336-340.
3. Karadeniz M, Erdogan M, Tamsel S, et al, 2008 Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin re-sistances. Exp Clin Endocrinol Diabetes 116: 231-235.
4. Kuscu NK, Var A, 2009 Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand 88: 612-617.
5. Macut D, Simic T, Lissounov A, et al, 2011 Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Exp Clin Endocrinol Diabetes 119: 451-455.
6. Gonzalez F, 2012 Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77: 300-305.
7. Gonzalez F, Nair KS, Daniels JK, Basal E, Schimke JM, 2012 Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. Am J Physiol Endocrinol Metab 302: E297-306.
8. Chignalia AZ, Schuldt EZ, Camargo LL, et al, 2012 Testosterone induces vascular smooth muscle cell migration by NADPH oxidase and c-Src-dependent pathways. Hypertension 59: 1263-1271.
9. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47.
10. Laven JS, Imani B, Eijkemans MJ, Fauser BC, 2002 New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57: 755-767.
11. Hatch R, Rosenfield RL, Kim MH, Tredway D, 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140: 815-830.
12. Macut D, Damjanovic S, Panidis D, et al, 2006 Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS. Eur J Endocrinol 155: 131-136.
13. Balen AH, Laven JS, Tan SL, Dewailly D, 2003 Ultra-sound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9: 505-514.
14. Matthews DR, Hosker JP, Rudenski AS, et al, 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
15. Katz A, Nambi SS, Mather K, et al, 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410.
16. Matsuda M, DeFronzo RA, 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
17. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, et al, 2006 Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens 20: 149-155.
18. Radovanovic S, Savic-Radojevic A, Pljesa-Ercegovac M, et al, 2012 Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure. J Card Fail 18: 493-501.
19. DeFronzo RA, Tobin JD, Andres R, 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-223.
20. Victor VM, Rocha M, Banuls C, et al, 2009 Mitochon-drial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 94: 3505-3512.
21. Jiang F, Zhang Y, Dusting GJ, 2011 NADPH oxidase-mediated redox signaling: roles in cellular stress re-sponse, stress tolerance, and tissue repair. Pharmacol Rev 63: 218-242.
22. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P, 1994 Nitric oxide release accounts for insulin’s vascular effects in humans. J Clin Invest 94: 2511-2515.
23. Song P, Wu Y, Xu J, et al, 2007 Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromo-some 10) in an LKB1-dependent manner. Circulation 116: 1585-1595.
24. Ceriello A, Esposito K, Piconi L, et al, 2008 Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57: 1349-1354.
25. Zou MH, Cohen R, Ullrich V, 2004 Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97.
26. Baskol G, Aygen E, Erdem F, et al, 2012 Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 91: 326-330.
27. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M, 2000 Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183.
28. Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, et al, 2011 Inflammation, oxidative stress, and obesity. Int J Mol Sci 12: 3117-3132.
29. Vrbikova J, Cibula D, Dvorakova K, et al, 2004 Insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89: 2942-2945.
30. Ciampelli M, Fulghesu AM, Cucinelli F, et al, 1997 Heterogeneity in beta cell activity, hepatic insulin clear-ance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 12: 1897-1901.
31. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS, 2000 Insulin sensitivity, insulin secretion, and metabolic and hormonal param-eters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 15: 1266-1274.
32. Muniyappa R, Lee S, Chen H, Quon MJ, 2008 Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294: E15-26.
33. Yoo TW, Sung KC, Shin HS, et al, 2005 Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69: 928-933.
34. Duleba AJ, Foyouzi N, Karaca M, et al, 2004 Prolif-eration of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress. Hum Reprod 19: 1519-1524.
35. Kodaman PH, Duleba AJ, 2008 HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? Drugs 68: 1771-1785.